APR 06, 2018 4:07 AM PDT

New Diagnostic Test for Lyme Disease

WRITTEN BY: Kara Marker

Diagnostic tests for Lyme disease, or Lyme neuroborreliosis (LNB) can take up to a week, but patients affected need antibiotics as soon as possible to prevent the risk of life-long symptoms. A new test, developed thanks to Finnish company Reagena and University of Turku scientists, will speed up the process.

This photomicrograph reveals the presence of the spirochaete bacteria known as Borrelia burgdorferi, which is the pathogen that causes Lyme disease. Credit: CDC Public Health Image Library

LNB is spread by ticks and affects the nervous system, caused by the bacterial species Borrelia burgdorferi. It’s the most common vector-borne disease in the United States; there are 20,000 new cases reported every year. LNB infection occurs in stages.

First, after about three days of infection to up to a month after, many patients experience a target-like rash. Then comes neurologic abnormalities and cardiac involvement in some patients for several months. Musculoskeletal pain and chronic arthritis in large joints, often the knee, can last for years.

The characteristic rash doesn’t always appear, in which case someone might not know they were bit by a tick at all, let alone that they have LNB. The new diagnostic test could help affected people receive antibiotic treatment as soon as possible as well as help avoid unnecessary antibiotic use, reducing the contribution to antibiotic resistance.

Current tests for LNB include looking for infection symptoms, cerebrospinal fluid tests, and antibody production from an activated immune response. The newer test is faster and able to

target antibiotic treatment to people with a high chance of having or developing neuroborreliosis, which can reduce the risk of post-treatment symptoms related to the infection.

The new test detects LNB by measuring concentration of a cytokine called CXCL13 in cerebrospinal fluid. High CXCL13 is a clear and well-known sign of untreated neuroborreliosis. It increases faster during neuroborreliosis than antibiotic concentrations do, and it declines quickly after antibiotic treatment starts.

“We have demonstrated that this point-of-care test is extremely efficient,” explained Jukka Hytonen from the University of Turku, who developed the idea for the new test. “As a result, we suggest that the diagnostic practice for neuroborreliosis in Finland would be reorganised so that the CXCL13 concentration would be measured immediately after the lumbar puncture for cerebrospinal fluid.”

The present study was published in the journal Diagnostic Microbiology & Infectious Disease.

Sources: American Journal of Neuroradiology, University of Turku

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JAN 08, 2020
Clinical & Molecular DX
JAN 08, 2020
MicroRNA emerges as a biomarker for migraines
Intense, debilitating pain that can last for days. Nausea, numbness and sensitivity to light. For people who experience ...
JAN 19, 2020
Immunology
JAN 19, 2020
Overactive Immune Gene May Cause Schizophrenia
A windy road links excessive activity of the “C4” gene to the development of schizophrenia. Researchers begi ...
FEB 10, 2020
Microbiology
FEB 10, 2020
As Ebola Outbreak Continues, Researchers Create Faster Genetic Test
Since 2013, around 30,000 people have been infected during several outbreaks of Ebola in eight different countries.
MAR 29, 2020
Genetics & Genomics
MAR 29, 2020
Biomarkers That Predict Crohn's Disease Are Identified
A series of studies published in Gastroenterology has outlined new approaches in predicting IBD.
APR 01, 2020
Microbiology
APR 01, 2020
How Two Types of Tests for COVID-19 Work
There are a couple of different kinds of tests that researchers will be developing and clinicians will be using to disru ...
MAY 12, 2020
Clinical & Molecular DX
MAY 12, 2020
Could Catching the Flu Be Linked to an Increased Cancer Risk?
Results from a new research study suggest that a spike in infections such as influenza could be linked to the risk of de ...
Loading Comments...